Dr. Jain is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Elm and Carlton St
Buffalo, NY 14263Phone+1 716-845-2300Fax+1 716-845-8518
Summary
- Dr. Prantesh Jain is an Oncologist specializing in Thoracic Cancer, based in Buffalo, NY. He completed his residency in Internal Medicine at Cook County Health and Hospitals System in 2013, a fellowship in Hematology and Medical Oncology at Case Western Reserve University/University Hospitals Cleveland Medical Center in 2021, along with further training in Internal Medicine. He has been employed at Roswell Park Comprehensive Cancer Center since 2021 and has specific experience in lung cancer. Dr. Jain has authored several publications in reputable medical journals, with research interests revolving around effects of treatments in various cancers. He has received commendations for his work, including the second prize in the critical data hackathon from MIT Boston in 2014 and a student research award from Indian Council of Medical Research in 2006. His medical education was completed at Kasturba Medical College Manipal, graduating in 2009.
Education & Training
- Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 2018 - 2021
- Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Internal Medicine, 2021
- University Hospitals Cleveland Medical CenterInternal Medicine, 2021
- Cook County Health and Hospitals SystemResidency, Internal Medicine, 2010 - 2013
- Kasturba Medical College ManipalClass of 2009
Certifications & Licensure
- NY State Medical License 2021 - 2026
- OH State Medical License 2013 - 2022
- IL State Medical License 2010 - 2013
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Second prize in critical data hackathon (Team Award) MIT Boston, 2014
- Second prize in clinical vignette presentation at 6th annual resident research and poster day, John H. Stroger Hospital of Cook County 2011
- First in 20th zonal quiz Indian Academy of Pediatrics, 2008
- Join now to see all
Publications & Presentations
PubMed
- Under-Representation and Under-Reporting of Minoritized Racial and Ethnic Groups in Clinical Trials on Immune Checkpoint Inhibitors.Alfredo V Chua Jr, Jennifer Delmerico, Haiyang Sheng, Xin-Wei Huang, Emily Liang
JCO Oncology Practice. 2025-03-01 - Phase II Study of Nanoliposomal Irinotecan (Nal-IRI) with 5-Fluorouracil and Leucovorin in Refractory Advanced High-Grade Neuroendocrine Cancer of Gastroenteropancreat...Sarbajit Mukherjee, Harsha Pattnaik, Sahithi Sonti, Mrinalini Ramesh, Prantesh Jain
Cancers. 2025-01-12 - Obesity-Specific improvement of lung cancer outcomes and immunotherapy efficacy with metformin.Randall J Smith Jr, Robert Zollo, Sukumar Kalvapudi, Yeshwanth Vedire, Akhil Goud Pachimatla
Journal of the National Cancer Institute. 2024-11-19
Journal Articles
- Afatinib and Lung CancerKhunger M., Jain P., Rakshit S., Pasupuleti V., Hernandez V., Stevenson V., Jain P., Khanal R., Yan F., Sharma N.Pennell N., Velcheti V., Expert Review of Anticancer Therapy, 1/1/2014
- Isolated zinc deficiency causing severe microcytosis and sideroblastic anemiaGupta S., Jain P., Sukhal S., Turk J Haematol, 1/1/2014
- Breast cancer with brain metastases in pregnancyGupta S., Jain P., McDunn S., The Journal of Community and Supportive Oncology, 1/1/2014
- Join now to see all
Abstracts/Posters
- Prediction of response to trimodality therapy using CT derived radiomic features in locally advanced stage III non-small cell lung cancer (NSCLC)Jain P., Khorrami M., Bera K., Ahmad U., Murthy S., Stephans K., Madabhushi A., Velcheti V., IASCLC World Lung Cancer, 1/1/2017
- ERBB receptor feedback inhibitor-1 alterations in non-small cell lung cancerSchneider J., Jain P., Schalper K., Lovly C., Gardner F., Ross J., Schrock A., Ali S., Miller V., Velcheti V., IASCLC World Lung Cancer, 1/1/2017
- Efficacy of PD-1/PD- L1 inhibitors in the front-line setting as compared to previously treated patientsJain P., Khunger M., Pasupuleti V., Hernandez A., Velcheti V., J Clin Oncol, 1/1/2017
- Join now to see all
Professional Memberships
- Associate
- Member
Other Languages
- Hindi
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: